Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Other Non-Current Liabilities of $20000.0 for Q1 2026, little changed sequentially from $20000.0 in Q4 2025, and little changed YoY from $20000.0 in Q1 2025.
Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Other Non-Current Liabilities for 9 years, with the latest figure at $20000.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $20000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities held at $20000.0 in Q1 2026 per ADPT's latest filing, from $20000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $128.2 million in Q2 2023 and troughed at $20000.0 in Q2 2024.
- A 5-year average of $42.1 million and a median of $20000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities soared 4721.54% in 2022, then slumped 99.98% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $125.4 million in 2022, then grew by 2.24% to $128.2 million in 2023, then plunged by 99.98% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025, then changed by 0.0% to $20000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $20000.0, $20000.0, and $20000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2023 | 128.17 Mn |
| Mar 31, 2023 | 127.01 Mn |
| Dec 31, 2022 | 125.36 Mn |
| Sep 30, 2022 | 124.56 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Dec 31, 2020 | 2.60 Mn |
| Sep 30, 2020 | 2.38 Mn |
| Jun 30, 2020 | 1.50 Mn |
| Dec 31, 2019 | 93,000.00 |
| Sep 30, 2019 | 44,000.00 |
| Jun 30, 2019 | 2.60 Mn |
| Dec 31, 2018 | 336,000.00 |